Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FP8VV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,323
Award facts
- Contract value 100% obligated
- $12,323.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,323.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units), with an ultimate completion date of January 26, 2026. This non-set-aside contract was competitively awarded and represents a task order executed against AmerisourceBergen's parent company, Cencora, Inc.'s, substantial indefinite delivery contract with DLA Troop Support Medical valued at up to $999.99 million through December 2031. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement.
This delivery order supports DLA's medical supply chain operations serving military healthcare systems and other federal government agencies. Vraylar, an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, represents the type of specialty pharmaceutical products that AmerisourceBergen routinely supplies through its comprehensive IDC vehicle. The parent IDC framework enables efficient procurement of a broad spectrum of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized medical devices—across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FP8VV?
SPE2DR26FP8VV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FP8VV worth?
The government has obligated $12,323 on SPE2DR26FP8VV.
Is contract SPE2DR26FP8VV an order under another contract?
Yes. SPE2DR26FP8VV is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8VV competed?
The extent of competition for SPE2DR26FP8VV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award